Evotec SE
Evotec SE is a publicly listed drug discovery and development company headquartered in Hamburg, Germany. The company operates globally, largely through external alliances with pharmaceutical and biotechnology companies, academic institutions, patient advocacy groups, and venture capitalists. As of 31 December 2021 Evotec had a market capitalization of €7.5 billion and a pipeline of more than 130 partnered programs in discovery, pre-clinical development and clinical development.
If you'd bought from year…
Same habit, different start year. Each row shows what a constant habit's worth of EVT-DE would be worth today, had you started buying at that point in the asset's history.
| Started | $6/day$6/day coffee | $42/wk$42/week coffee |
|---|---|---|
| Year 1 (1999) — listing | $53,549 1.3× | $76,682 1.3× |
| Year 6 (2004) | $47,970 1.4× | $68,881 1.4× |
| Year 11 (2009) | $31,832 1.2× | $45,790 1.2× |
| Year 16 (2014) | $11,601 0.6× | $16,691 0.6× |
| Year 21 (2019) | $4,297 0.4× | $6,189 0.4× |
| Year 26 (2024) | $2,636 0.7× | $3,800 0.7× |
Repeated investment, no fees, dividends reinvested. $6/day coffee = $180 / month equivalent.
Headquarters
Hamburg, Germany
Popular scenarios with EVT
For illustration only — not investment advice. Past performance is not indicative of future results.